ReviewBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2026
Targeting CD38 Across Autoimmune and Plasma Cell-Driven Immune-Mediated Diseases: Rationale, Clinical Evidence, and Emerging Therapeutic Landscape.
Dario Roccatello et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.